Residues essential for plasminogen binding by the cation-independent mannose 6-phosphate receptor

Biochemistry

Volumn 49, Issue 3, 2010, Pages 635-644

  Bohnsack, Richard N ^a   Patel, Manish ^a   Olson, Linda J ^a   Twining, Sally S ^a   Dahms, Nancy M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTORS; EXTRACELLULAR LIGANDS; EXTRACYTOPLASMIC; HIGH AFFINITY; KEY DETERMINANTS; LYSINE RESIDUES; LYSINE-BINDING SITES; MOLECULAR BASIS; MULTIFUNCTIONAL PROTEIN; N-TERMINALS; SERINE PROTEASE; SITE DIRECTED MUTAGENESIS;

AMINO ACIDS; BINDING ENERGY; BIOCHEMISTRY; ENZYME ACTIVITY; PHOSPHATASES; POSITIVE IONS; SURFACE PLASMON RESONANCE;

BINDING SITES;

LYSINE DERIVATIVE; MANNOSE 6 PHOSPHATE; PLASMINOGEN; SERINE PROTEINASE; SOMATOMEDIN B RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CYTOPLASM; KRINGLE DOMAIN; LIGAND BINDING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; SURFACE PLASMON RESONANCE;

ANIMALS; BINDING SITES; CATIONS; CATTLE; HUMANS; KINETICS; KRINGLES; LIGANDS; LYSINE; PLASMINOGEN; RECEPTOR, IGF TYPE 2; SUBSTRATE SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 74949084342     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi901779p     Document Type: Article

References (60)

1. Tordai, H., Banyai, L., and Patthy, L. (1999) The PAN module: the N-terminal domains of plasminogen and hepatocyte growth factor are homologous with the apple domains of the prekallikrein family and with a novel domain found in numerous nematode proteins. FEBS Lett. 461, 63-67.
2. Castellino, F. J., and Ploplis, V. A. (2005) Structure and function of the plasminogen/plasmin system. Thromb. Haemostasis 93, 647-654.
3. Sehl, L. C., and Castellino, F. J. (1990) Thermodynamic properties of the binding of alpha-, omega-amino acids to the isolated kringle 4 region of human plasminogen as determined by high sensitivity titration calorimetry. J. Biol. Chem. 265, 5482-5486.
4. Hoover, G. J., Menhart, N., Martin, A., Warder, S., and Castellino, F. J. (1993) Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with omega-amino acids. Biochemistry 32, 10936-10943.
5. Menhart, N., and Castellino, F. J. (1995) The importance of the hydrophobic components of the binding energies in the interaction of omega-amino acid ligands with isolated kringle polypeptide domains of human plasminogen. Int. J. Pept. Protein Res. 46, 464-470.
6. Nilsen, S. L., Prorok, M., and Castellino, F. J. (1999) Enhancement through mutagenesis of the binding of the isolated kringle 2 domain of human plasminogen to omega-amino acid ligands and to an internal sequence of a streptococcal surface protein. J. Biol. Chem. 274, 22380-22386.
7. Cao, Y., and Xue, L. (2004) Angiostatin. Semin. Thromb. Hemostasis 30, 83-93.
8. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
9. Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinas, M., and Folkman, J. (1996) Kringle domains of human angiostatin. Characterization of the antiproliferative activity on endothelial cells. J. Biol. Chem. 271, 29461-29467.
10. Cao, Y., Chen, A., An, S. S., Ji, R. W., Davidson, D., and Llinas, M. (1997) Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928.
11. Cao, R., Wu, H. L., Veitonmaki, N., Linden, P., Farnebo, J., Shi, G. Y., and Cao, Y. (1999) Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl. Acad. Sci. U.S.A. 96, 5728-5733.
12. Binder, B. R., Mihaly, J., and Prager, G. W. (2007) uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb. Haemostasis 97, 336-342.
13. Dass, K., Ahmad, A., Azmi, A. S., Sarkar, S. H., and Sarkar, F. H. (2008) Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev. 34, 122-136.
14. Kornfeld, S. (1992) Structure and function of the mannose 6-phosphate/ insulinlike growth factor II receptors. Annu. Rev. Biochem. 61, 307-330.
15. Dennis, P. A., and Rifkin, D. B. (1991) Cellular activation of latent transforming growth factor beta requires binding to the cationindependent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. U.S.A. 88, 580-584.
16. Tong, P. Y., Tollefsen, S. E., and Kornfeld, S. (1988) The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II. J. Biol. Chem. 263, 2585-2588.
17. Kang, J. X., Li, Y., and Leaf, A. (1997) Mannose-6-phosphate/ insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 94, 13671-13676.
18. Nykjaer, A., Christensen, E. I., Vorum, H., Hager, H., Petersen, C. M., Roigaard, H., Min, H. Y., Vilhardt, F.,Moller, L. B.,Kornfeld, S., and Gliemann, J. (1998)Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J. Cell Biol. 141, 815-828.
19. Godar, S., Horejsi, V., Weidle, U. H., Binder, B. R., Hansmann, C., and Stockinger, H. (1999) M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur. J. Immunol. 29, 1004-1013.
20. Olson, L. J., Yammani, R. D., Dahms, N. M., and Kim, J. J. (2004) Structure of uPAR, plasminogen, and sugar-binding sites of the 300 kDa mannose 6-phosphate receptor. EMBO J. 23, 2019-2028.
21. Brown, J., Delaine, C., Zaccheo, O. J., Siebold, C., Gilbert, R. J., van Boxel,G., Denley, A., Wallace, J. C., Hassan, A. B., Forbes, B. E., and Jones, E. Y. (2008) Structure and functional analysis of the IGF-II/ IGF2R interaction. EMBO J. 27, 265-276.
22. Uson, I., Schmidt, B., von Bulow, R., Grimme, S., von Figura, K., Dauter, M., Rajashankar, K. R., Dauter, Z., and Sheldrick, G. M. (2003) Locating the anomalous scatterer substructures in halide and sulfur phasing. Acta Crystallogr., Sect. D: Biol. Crystallogr. 59, 57-66.
23. Reddy, S. T., Chai, W., Childs, R. A., Page, J. D., Feizi, T., and Dahms, N. M. (2004) Identification of a low affinity mannose 6-phosphate-binding site in domain 5 of the cation-independent mannose 6-phosphate receptor. J. Biol. Chem. 279, 38658-38667.
24. Hancock, M. K., Yammani, R. D., and Dahms, N. M. (2002) Localization of the carbohydrate recognition sites of the insulin-like growth factor II/mannose 6-phosphate receptor to domains 3 and 9 of the extracytoplasmic region. J. Biol. Chem. 277, 47205-47212.
25. Devi, G. R., Byrd, J. C., Slentz, D. H., and MacDonald, R. G. (1998) An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor. Mol. Endocrinol. 12, 1661-1672.
26. Linnell, J., Groeger, G., and Hassan, A. B. (2001) Real time kinetics of insulin-like growth factor II (IGF-II) interaction with the IGF-II/ mannose 6-phosphate receptor. The effects of domain 13 and pH. J. Biol. Chem. 276, 23986-23991.
27. Leksa, V., Godar, S., Cebecauer, M., Hilgert, I., Breuss, J., Weidle, U. H., Horejsi, V., Binder, B. R., and Stockinger, H. (2002) The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration. J. Biol. Chem. 277, 40575-40582.
28. Ghahary, A., Tredget, E. E., Mi, L., and Yang, L. (1999) Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells. Exp. Cell Res. 251, 111-120.
29. Ghahary, A., Tredget, E. E., Shen, Q., Kilani, R. T., Scott, P. G., and Houle, Y. (2000) Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-1- induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts. Growth Factors 17, 167-176.
30. Munger, J. S., Harpel, J. G., Gleizes, P. E., Mazzieri, R., Nunes, I., and Rifkin, D. B. (1997) Latent transforming growth factor-beta - structural features and mechanisms of activation. Kidney Int. 51, 1376-1382.
31. Villevalois-Cam, L., Rescan, C., Gilot, D., Ezan, F., Loyer, P., Desbuquois, B., Guguen-Guillouzo, C., and Baffet, G. (2003) The hepatocyte is a direct target for transforming-growth factor beta activation via the insulin-like growth factor II/mannose 6-phosphate receptor. J. Hepatol. 38, 156-163.
32. Leksa, V., Godar, S., Schiller, H. B., Fuertbauer, E., Muhammad, A., Slezakova, K., Horejsi, V., Steinlein, P., Weidle, U. H., Binder, B. R., and Stockinger, H. (2005) TGF-beta-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen. J. Cell Sci. 118, 4577-4586.
33. 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J. Biol. Chem. 260, 9435-9442.
34. Ludwig, T., Eggenschwiler, J., Fisher, P., D'Ercole, A. J., Davenport, M. L., and Efstratiadis, A. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol. 177, 517-535.
35. Valenzano, K. J., Remmler, J., and Lobel, P. (1995) Soluble insulinlike growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum. J. Biol. Chem. 270, 16441-16448.
36. Marron-Terada, P. G., Hancock, M. K., Haskins, D. J., and Dahms, N. M. (2000) Recognition of Dictyostelium discoideum lysosomal enzymes is conferred by the amino-terminal carbohydrate binding site of the insulin-like growth factor II/mannose 6-phosphate receptor. Biochemistry 39, 2243-2253.
37. Reddy, S. T., and Dahms, N. M. (2002) High-level expression and characterization of a secreted recombinant cation-dependent mannose 6-phosphate receptor in Pichia pastoris. Protein Expression Purif. 26, 290-300.
38. Marron-Terada, P. G., Bollinger, K. E., and Dahms, N. M. (1998) Characterization of truncated and glycosylation-deficient forms of the cation-dependent mannose 6-phosphate receptor expressed in baculovirus-infected insect cells. Biochemistry 37, 17223-17229.
39. Myszka, D. G. (2000) Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIACORE. Methods Enzymol. 323, 325-340.
40. Kiess, W., Greenstein, L. A., White, R. M., Lee, L., Rechler, M. M., and Nissley, S. P. (1987) Type II insulin-like growth factor receptor is present in rat serum. Proc. Natl. Acad. Sci. U.S.A. 84, 7720-7724.
41. Causin, C.,Waheed, A., Braulke, T., Junghans, U., Maly, P., Humbel, R. E., and von Figura, K. (1988) Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor. Biochem. J. 252, 795-799.
42. MacDonald, R. G., Tepper, M. A., Clairmont, K. B., Perregaux, S. B., and Czech, M. P. (1989) Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxylterminal domain. J. Biol. Chem. 264, 3256-3261.
43. Xu, Y., Papageorgiou, A., and Polychronakos, C. (1998) Developmental regulation of the soluble form of insulin-like growth factor-II/ mannose 6-phosphate receptor in human serum and amniotic fluid. J. Clin. Endocrinol. Metab. 83, 437-442.
44. Olson, L. J., Dahms, N. M., and Kim, J. J. (2004) The N-terminal carbohydrate recognition site of the cation-independent mannose 6-phosphate receptor. J. Biol. Chem. 279, 34000-34009.
45. Tong, P. Y., and Kornfeld, S. (1989) Ligand interactions of the cationdependent mannose 6-phosphate receptor. Comparison with the cation-independent mannose 6-phosphate receptor. J. Biol. Chem. 264, 7970-7975.
46. MacDonald, R. G., Pfeffer, S. R., Coussens, L., Tepper, M. A., Brocklebank, C. M., Mole, J. E., Anderson, J. K., Chen, E., Czech, M. P., and Ullrich, A. (1988) A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239, 1134-1137.
47. Marshall, J. M., Brown, A. J., and Ponting, C. P. (1994) Conformational studies of human plasminogen and plasminogen fragments: evidence for a novel third conformation of plasminogen. Biochemistry 33, 3599-3606.
48. Urano, T., Sator de Serrano, V., Chibber, B. A., and Castellino, F. J. (1987) The control of the urokinase-catalyzed activation of human glutamic acid 1-plasminogen by positive and negative effectors. J. Biol. Chem. 262, 15959-15964.
49. Warejcka, D. J., and Twining, S. S. (2005) Specific conformational changes of plasminogen induced by chloride ions, 6-aminohexanoic acid and benzamidine, but not the overall openness of plasminogen regulate, production of biologically active angiostatins. Biochem. J. 392, 703-712.
50. Doolittle, R. F. (2008) Searching for differences between fibrinogen and fibrin that affect the initiation of fibrinolysis. Cardiovasc. Hematol. Agents Med. Chem. 6, 181-189.
51. MacLeod, T. J., Kwon, M., Filipenko, N. R., and Waisman, D. M. (2003) Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J. Biol. Chem. 278, 25577-25584.
52. Frank, P. S., Douglas, J. T., Locher, M., Llinas, M., and Schaller, J. (2003) Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide. Biochemistry 42, 1078-1085.
53. Wang, H., Yu, A., Wiman, B., and Pap, S. (2003) Identification of amino acids in antiplasmin involved in its noncovalent "lysinebinding-site"- dependent interaction with plasmin. Eur. J. Biochem. 270, 2023-2029.
54. Graversen, J. H., Jacobsen, C., Sigurskjold, B. W., Lorentsen, R. H., Moestrup, S. K., Thogersen, H. C., and Etzerodt, M. (2000) Mutational analysis of affinity and selectivity of kringle-tetranectin interaction. Grafting novel kringle affinity ontp the trtranectin lectin scaffold. J. Biol. Chem. 275, 37390-37396.
55. Rios-Steiner, J. L., Schenone, M., Mochalkin, I., Tulinsky, A., and Castellino, F. J. (2001) Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A streptococcal surface protein. J. Mol. Biol. 308, 705-719.
56. Wang, X., Lin, X., Loy, J. A., Tang, J., and Zhang, X. C. (1998) Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science 281, 1662-1665.
57. Loy, J. A., Lin, X., Schenone, M., Castellino, F. J., Zhang, X. C., and Tang, J. (2001) Domain interactions between streptokinase and human plasminogen. Biochemistry 40, 14686-14695.
58. Tharp, A. C., Laha, M., Panizzi, P., Thompson, M. W., Fuentes-Prior, P., and Bock, P. E. (2009) Plasminogen substrate recognition by the streptokinase-plasminogen catalytic complex is facilitated by Arg253, Lys256, and Lys257 in the streptokinase {beta}-domain and kringle 5 of the substrate. J. Biol. Chem. 284, 19511-19521.
59. Abad, M. C., Arni, R. K., Grella, D. K., Castellino, F. J., Tulinsky, A., and Geiger, J. H. (2002) The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin. J. Mol. Biol. 318, 1009-1017.
60. DeLano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific LLC, San Carlos, CA.